Agios Pharma (AGIO) Tops Q2 EPS by 6c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.31), $0.06 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $37.35 million versus the consensus estimate of $37.71 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Radoff-Jumana Group calls for Genesco CEO to lose board chair role
• Harley-Davidson (HOG) PT Raised to $30 at DA Davidson: 'Moving in The Right Direction'